17 April 2014
OOO Fort, a Russian company, is launching a new pharmaceutical facility outside the city of Ryazan in Central Russia later this week, the Uzrf.ru portal for Russian healthcare institutions reported .
At inception, a small workshop will open in the village of Yaltunovo; further plans are for the new project to be adding production capacity as it evolves. Longer term, the new pharma is expected to create as many as 900 new skilled local jobs.
The factory will be manufacturing nano- and biotech-based drugs to treat infectious and somatic diseases. They have been developed by Fort’s own R&D staff in collaboration with a number of leading research centers of the Russian Academy of Medical Sciences.
The Ryazan project has taken about 30 months of construction and more than $130m in investment to complete.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Four cancer centers opened in Russia in 2023
26 April 2024
Russia and the UAE can simplify the drug registration process
26 April 2024
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024